FEBRUARY 20, 2021 | VIRTUAL

Spring Clinical Conference 2021

VIRTUAL

Proudly Presented by the

ARIZONA PHARMACY ASSOCIATION -state affiliate of ASHP

This 1-day virtual seminar provides up to 15 hours of continuing education for pharmacy professionals focusing on clinical topics pertinent to institutional and ambulatory care settings.

 

Registration Fees

 Member Prices
Premium Pharmacist: $124
Pharmacist: $144
Resident/Technician/Associate: $84
Student:  $50

Non-Member Prices
Pharmacist: $184
Resident/Technician/Associate: $114
Student: $60

Agenda

7:00-8:00 AM  | Az-ASHP Delegate Townhall
Mindy Burnworth, PharmD, BCPS, FASHP, FAzPA; Christi Jen, PharmD, BCPS, FAzPA; Christopher Edwards, PharmD, BCPS; Carol Rollins, PharmD, BCNSP, FASHP, FASPEN, FAzPA; Danielle Kamm, PharmD; Janelle Duran, PharmD, BCPS

Pharmacist/Technician learning objectives:

  • Identify methods of moving a pharmacy practice initiative forward through the ASHP House of Delegates.
  • Describe the role of Arizona delegates to the ASHP House of Delegates
  • Recognize the impact of selected policies coming before the ASHP House of
  • Delegates in June 2021 to the practice of pharmacy in Arizona and pharmacy personnel.

ACPE UAN 0100-0000-21-001-L03-P/T

 

7:00-8:00 AM | Zooming Through a Virtual Rotation!
Bernadette Cornelison, PharmD, MS, BCPS, Beth Zerr, PharmD, BCACP

Pharmacist learning objectives: (Pharmacists only)

  • Implement virtual activities that will prepare students with the knowledge and skills required to practice as a community pharmacist.
  • Create a patient care simulation that is assessed through peer evaluation.

ACPE UAN 0100-0000-21-001-L04-P

 

8:05-9:05 AM  2021 Pharmacy Law Update
Roger Morris, RPh, JD; Ashley Strait, JD

Pharmacist/Technician learning objectives:

  • Identify major developments in U.S. Pharmacy law and related fields.
  • Describe the practical ramifications of proposed state and national legislative initiatives.
  • Recognize emerging patterns that will broadly affect the healthcare profession and pharmacy practice.

ACPE UAN 0100-0000-21-002-L03-P/T

 

8:05-9:05 AM | New Directions in Influenza Management: The Pharmacist’s Guide to Patient Identification, Testing, and Antiviral Use
James S. Lewis II, PharmD, FIDSA

Pharmacist learning objectives: (Pharmacists only)

  • Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
  • Assess the need for influenza treatment based on patient signs, symptoms, and accurate interpretation of appropriate diagnostic tests when necessary
  • Recommend individualized antiviral treatment plans for patients with, or at risk for, influenza in accordance with the latest evidence

ACPE # 0221-9999-20-243-L04-P  (ProCE, Inc. accredited this program – Not an AzPA activity)

 

9:30-10:30 AM | ASHP Update:  COVID-19 Pandemic’s Impact on Pharmacy Scope of Practice and Reimbursement
Kyle Robb, PharmD, BCPS

Pharmacist/Technician learning objectives:

  • Review details of the federal public health emergency waivers that temporarily expanded pharmacist-led vaccinating authority.
  • Describe state efforts to expand pharmacist and pharmacy technician scope-of-practice during the pandemic.
  • Discuss strategies to maximize pharmacy's involvement in pandemic response and plans to retain expanded roles beyond.
  • Analyze the pandemic’s overall impact on ongoing efforts to advance pharmacy practice and secure reimbursement for services.

ACPE UAN 0100-9999-21-003-L03-P/T

 

10:35-11:35 AM | Introduction to Emergency Management and the Point of Dispensing

Laura Dix, MS; Edward Valiniski

Pharmacist/Technician Learning Objectives:

  • Discuss the basic tenets of emergency management and preparedness and the role of healthcare coalitions.
  • Describe points of dispensing and their role during the COVID pandemic.
  • Identify where a pharmacist or technician may be involved in the continuum of emergency management.

ACPE UAN 0100-0000-21-019-L04-P/T

 

10:35-11:35 AM | The Need for an “Agnostic” Drug to Treat Drug Overdose
Robert Raffa, PhD; Sumiyo Umeda-Raffa, PhD

Pharmacist/Technician learning objectives:

  • Recognize the challenges that fentanyl and polysubstance abuse (PSA) present to drug overdose.
  • Describe the mechanistic reason that naloxone is less effective against PSA.
  • Define the medical need for a non-opioid “agnostic” pharmacologic treatment for PSA.

ACPE UAN 0100-0000-21-008-L08-P/T

 

10:35-11:35 AM | The COVID-19 Impact on Antibiotic Stewardship
Mandana Naderi, PharmD, BCIDP; Juan Villanueva, PharmD, BCPS, BCIDP

Pharmacist learning objectives:

  • Describe current trends in antibiotic use seen during the COVID-19 pandemic.
  • Recognize antibiotic resistance trends observed during the COVID-19 pandemic and potential impacts on patient care.
  • Identify appropriate and effective antibiotic stewardship strategies to incorporate during COVID-19 pandemic.

Technician learning objectives:

  • Describe current trends in antibiotic use seen during the COVID-19 pandemic.
  • Recognize antibiotic resistance trends observed during the COVID-19 pandemic

ACPE UAN 0100-0000-21-004-L01-P/T

 

12:15-1:15 PM  | COVID19 and Pharmacogenomics: An Association that Warrants Comprehensive Assessment
Adrijana Kekic, PharmD, BCACP, CTLC

Pharmacist/Technician learning objectives:

  • Assess the role of genetics in COVID-19 disease predisposition and severity.
  • Compare the impact of genes in pharmacotherapy used for management of COVID-19 patients.

ACPE UAN 0100-0000-21-006-L01-P/T

 

1:20-2:20 PM | Developing Critical Thinking Skills in Your Trainee
Carol Rollins, PharmD, BCNSP, FASHP, FASPEN, FAzPA

Pharmacist learning objectives: (Pharmacists only)

  • Given a vignette, identify the indicators of poor critical thinking in a trainee.
  • Discuss methods that can be incorporated into the trainee’s program to develop critical thinking skills.
  • Develop a plan to address a resident's poor critical thinking skills, identifying both resident and preceptor actions that can be taken.

ACPE UAN 0100-0000-21-014-L04-P

 

1:20-2:20 PM | High-Risk Medications (HRMs): Their Safety, Impact on Star Ratings, and Safer Alternatives
Parixit Modi, PharmD

Pharmacist learning objectives:

  • Identify high-risk medications and their impact on Medicare Star Rating.
  • Recognize commonly prescribed high-risk medications, indications, side effects, and their safety and effectiveness in the elderly population.
  • Identify the standard counseling points and their safer alternatives.

Technician learning objectives:

  • Identify high-risk medications and their impact on Medicare Star Rating.
  • Recognize commonly prescribed high-risk medications and their safety and effectiveness in the elderly population.

ACPE UAN 0100-0000-21-007-L05-P/T


2:40-3:40 PM | One Size Doesn't Fit All: Cardiovascular Health in Special Populations

Kimberly Langley, PharmD, MBA, BCPS; MaryJo Zunic, PharmD, BCACP, BC-ADM, CDCES; Joseph Nardilillo, PharmD; Corinne Easterling, PharmD

Pharmacist learning objectives:  (Pharmacists only)

  • Review cardiovascular guidelines for primary prevention.
  • For select populations, recognize and review unique factors that may contribute to cardiovascular risk and how to manage.
  • Review cardiovascular assessments and therapeutic treatments that should be considered in special populations.
  • Apply cardiovascular risk considerations to a special patient population case.

ACPE UAN 0100-0000-21-009-L01-P

 

2:40-3:40 PM | What You Didn’t Know About Continuous Glucose Monitoring or CGM: A Primer for Pharmacists
Brad Ordener, PharmD, BCPS

Pharmacist learning objectives:

  • Identify disease states in which CGM use is common.
  • Describe the capabilities and functions of CGM devices.
  • Discuss attributes and individual components of CGM systems.
  • Recall which patients may benefit from CGM use.

ACPE UAN 0100-0000-21-005-L01-P

 

2:40-3:40 PM | Fundamentals for Evaluating and Interpreting Real-World Evidence
Barbara Perry, PharmD, MPH; Jon Glover, PharmD

Pharmacist learning objectives:  (Pharmacists only)

  • Describe the challenges within the United States healthcare landscape.
  • Describe how Real-world data (RWD) is used to generate Real-world evidence (RWE).
  • Review guidelines to evaluate RWE studies.
  • Identify how RWE can be used in healthcare decision-making.
  • List the components/framework for RWE.

ACPE UAN 0100-0000-21-010-L04-P

 

3:45-4:45 PM | COVID-19 Vaccine Update
Kelly Fine, RPh, FAzPA

Pharmacist/Technician learning objectives:

  • Identify the differences and similarities between the COVID-19 vaccines that have received an Emergency Use Authorization.
  • Describe vaccine adverse event reporting for COVID-19 vaccines.
  • Demonstrate proper immunization administration techniques to avoid SIRVA.

ACPE UAN 0100-0000-21-017-L06-P

 

3:45-4:45 PM | Advances in Pharmacotherapy: New Drugs Update 2021
Robert J. Lipsy, PharmD, BCACP, FASHP, FAzPA

Pharmacist learning objectives:

  • Compare and contrast newly approved medications to current ones used to treat the same condition.
  • Identify the most appropriate medication to treat a condition based on population and individual patient information.
  • Describe the risks and benefits of new medications to other healthcare providers.

Technician learning objectives:

  • Aid the pharmacist in choosing the most appropriate drug therapy by providing medication information.
  • Recognize what laboratory tests are usually association with a specific condition.
  • List the appropriate way(s) to store medications following dispensing.

ACPE UAN 0100-0000-21-011-L01-P/T

SPONSORS